OB
AI platform for drug discovery and development, optimizing targets, compounds, and combination therapies.
About
OneThree Biotech is a biology-driven artificial intelligence company that accelerates drug discovery and development. Their platform integrates diverse data types to identify novel targets, optimize compounds for toxicity and efficacy, and discover new therapeutic combinations. They aim to provide deeper mechanistic insights into drug action, improving the accuracy and success rate of preclinical R&D.
Tags
Performance
Company Timeline
No timeline data for this period
Discussion (0)
Join the discussion
No comments yet. Be the first to share your thoughts!
Frequently Asked Questions
What does OneThree Biotech do?
OneThree Biotech is a biology-driven artificial intelligence company that accelerates drug discovery and development. Their platform integrates diverse data types to identify novel targets, optimize compounds for toxicity and efficacy, and discover new therapeutic combinations. They aim to provide deeper mechanistic insights into drug action, improving the accuracy and success rate of preclinical R&D.
How much funding has OneThree Biotech raised?
OneThree Biotech has raised a total of $3M in funding. The most recent round on record is Seed.
Where is OneThree Biotech headquartered?
OneThree Biotech is headquartered in New York City, United States.
When was OneThree Biotech founded?
OneThree Biotech was founded in 2018.
What industry does OneThree Biotech operate in?
OneThree Biotech operates in Biotech, HealthTech, Drug Discovery, AI-Driven Protein Design, Genomics, Clinical Trials.
Similar Startups